BioInfra Co.,Ltd. Board approves small-scale absorption of wholly owned subsidiary in place of shareholder vote
BAI summary · Not investment advice
BioInfra Co.,Ltd. approved the absorption of its wholly owned subsidiary by board resolution, as dissenting shares fell short of the threshold. The merger date is November 17, 2026.
Key facts
- Merged company
- A wholly owned subsidiary100% owned subsidiary
- Merger method
- Absorption of the wholly owned subsidiary without issuing new shares (small-scale merger)
- Merger ratio
- 1 : 0No new shares issued
- Dissenting shares
- 57,503 shares1.18% of total shares outstanding
- Dissenting shareholders
- 132
- Dissent notice period
- Sep 28, 2026 – Oct 13, 2026
- Appraisal rights
- Not grantedSmall-scale merger procedure
- Merger date
- Nov 17, 2026
- Resolution result
- Merger approved as proposedBoard resolution in place of shareholders' meeting
- Decision date
- Oct 14, 2026
Commentary
AI commentary · Not investment advice
What happened
BioInfra gave final board approval to absorbing its wholly owned subsidiary. As a small-scale merger, it was approved by the board instead of a shareholders' meeting. No new shares are issued, so the merger ratio is 1 : 0.
In the company's terms
132 shareholders dissented, holding 57,503 shares. That is 1.18% of total shares, below the one-fifth threshold the company cited, so no shareholders' meeting is needed.
What changes for shareholders
The merger takes effect on 2026.11.17. Because it is a small-scale merger, dissenting shareholders have no appraisal rights (the right to ask the company to purchase their shares).
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist